We see an increase in variability in the responsiveness with AGPAT4 KD so that the means were also not significantly different from the OA treated cells; however, there was no significant difference from untreated PHT cells as well. The gene discussed is AGPAT4; the disease is pulmonary hypertension, primary, 1.